Article
Brochure
Insight Hub
Executive Resource
Ext. Publication
Video
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- ESG Strategy & Consulting
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Transaction Advisory
- Trust & Estate
- Valuation
The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.
Explore year-end considerations including the critical aspects of 45Z credits, ITC for biogas and strategies for clean fuel production credits.
Weaver has developed carbon accounting processes to determine our carbon footprint across Scope 1 and Scope 2 emissions.
Microsoft has reformed the calculation of its supply-chain emissions through innovative accounting to align with its carbon-negative 2030 goals. Learn more here.
With the implementation of the Canadian Clean Fuel Regulations (CFR) beginning in 2022, Canada added significant clean fuel requirements to the existing British Columbia Low Carbon Fuels Act (BC-LCFS).
Featured in The AHRC News online publication, Weaver partner Justin Gibert outlines the HFC audit requirements under the AIM Act, which ensures compliance with the phasedown of HFCs.
The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.
The biopharma industry has experienced a resurgence the first part of 2024. J.P. Morgan’s Q2 report shares critical insights into the future of the industry.
Ardent Health’s recent IPO highlights the company’s unique qualities, though it creates valuation comparability challenges for joint ventures and leased facilities.
The instances of urgent care clinic visits have returned to pre-pandemic levels, but COVID-related services still make up a large percentage of the total volume.
As Local Law 97 mandates emission reductions for large buildings in NYC, property owners are taking proactive steps to ensure compliance and avoid fines.
Featured in American Health Law Association’s online publication, Weaver partners Corey Palasota and Tashiana Briggs outline personal goodwill in health care M&A transactions.